The leaky gut: Reality, folklore, or the new frontier?
In this month’s “Virtual Lecture,” Michael Camilleri, M.D., discusses the leaky gut, including components of the intestinal barrier and how to measure its permeability. He also reviews literature about the effects that stress and diet have on permeability, and takes a futuristic look at barrier dysfunction in the context of inflammatory bowel disease.
Video length: 43 minutes
Michael Camilleri, M.D.
Professor of Medicine and Pharmacology and Physiology
Department of Gastroenterology and Hepatology
Mayo Clinic, Rochester, Minnesota
Upon completion of this program, participants should be able to:
This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.
The following types of credit are offered for this program:
Mayo Clinic Laboratories is approved as a provider of continuing education programs in the Clinical Laboratory Sciences by the ASCLS P.A.C.E.® program. This program has been approved for a maximum of 1.0 P.A.C.E.® contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for Clinical Laboratory Sciences for the State of California. This program has been approved for 1.0 contact hour.
Mayo Clinic Laboratories is approved as a Continuing Education Accrediting Agency for the Clinical Laboratory Sciences for the State of Florida. Florida Board of Clinical Laboratory Personnel has designated this program for General credit. This program has been approved for 1.0 contact hour.
1. Watch the video.
2. Complete the posttest and evaluation that launches immediately following the video.
3. Generate and print your certificate(s).
Level of instruction for this program is intermediate.
Course director(s), planning committee, faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty members also will disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentations. Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentations.
Contact us: email@example.com